Sartorius Aktiengesellschaft (SRT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SRT stock market capitalisation for the company's overall valuation and market capitalisation.
Sartorius Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency. Explore SRT cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Huafon Spandex Co Ltd
SHE:002064
|
0.055x |
|
Nkt A/S
NYSE:NRKBY
|
0.025x |
|
JD LOGISTICS DL-000025
F:822
|
N/A |
|
Lottomatica Group SpA
NYSE:LOTMY
|
0.362x |
|
ASHTEAD UNSP.ADR/4 LS-10
F:0LCA
|
N/A |
|
GS Holdings
KO:078930
|
0.041x |
|
Noble Corporation plc
NYSE:NE
|
0.060x |
|
UNO Minda Limited
NSE:UNOMINDA
|
0.093x |
Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2013–2025)
The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2025. View SRT stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€837.00 Million ≈ $978.54 Million |
0.216x | -13.58% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -15.90% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€821.30 Million ≈ $960.19 Million |
0.298x | +7.84% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -45.60% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
€873.20 Million ≈ $1.02 Billion |
0.508x | +39.15% |
| 2020-12-31 | €1.40 Billion ≈ $1.64 Billion |
€511.52 Million ≈ $598.03 Million |
0.365x | +4.57% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€377.19 Million ≈ $440.97 Million |
0.349x | +38.87% |
| 2018-12-31 | €973.39 Million ≈ $1.14 Billion |
€244.52 Million ≈ $285.87 Million |
0.251x | -1.89% |
| 2017-12-31 | €806.56 Million ≈ $942.95 Million |
€206.51 Million ≈ $241.43 Million |
0.256x | +10.70% |
| 2016-12-31 | €736.80 Million ≈ $861.40 Million |
€170.42 Million ≈ $199.24 Million |
0.231x | +18.96% |
| 2015-12-31 | €644.75 Million ≈ $753.78 Million |
€125.36 Million ≈ $146.56 Million |
0.194x | -25.39% |
| 2014-12-31 | €497.66 Million ≈ $581.82 Million |
€129.69 Million ≈ $151.62 Million |
0.261x | +13.63% |
| 2013-12-31 | €450.25 Million ≈ $526.39 Million |
€103.26 Million ≈ $120.72 Million |
0.229x | -- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more